openPR Logo

Press Releases from MNMConferences (24 total)

Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg, G …

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October

Upcoming Event on 'Orphan Drugs and Rare Diseases Conference - US Edition' | 17t …

Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving

Upcoming Conference on ImmunoBio Series | 14th - 15th October 2024 | Freiburg im …

Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October

MarketsandMarkets Probiotics Conference | 24th - 25th October 2024 | London, UK

The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the

Bridging Data to Decisions: Real-World Evidence and Life Science Analytics Expla …

We are thrilled to welcome you to the 7th Annual Real-World Evidence and Life Science Analytics Conference at Boston 2024, a premier gathering of thought

Bridging the Gap: Real-World Evidence & Market Access Summit

Join us at the MarketsandMarkets 2nd Annual Real-World Evidence and Market Access Conference, October 2024, Freiburg im Breisgau, Germany edition to be at the forefront

European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Survei …

In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on

Biomarker and Companion Diagnostics Conference | 20th - 21st June 2024 (Boston, …

MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Hilton Boston Logan Airport, One Drive, Boston, MA

(Boston, USA) | Next-Gen Immuno-Oncology Conference | 20th - 21st June 2024

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston,

MarketsandMarkets London Orthopaedic Meeting (Radisson Park Plaza Waterloo, 6 He …

We are pleased to announce the MarketsandMarkets London Orthopaedic Meeting, scheduled for 13th-14th June 2024, in Radisson Park Plaza Waterloo, 6 Hercules Rd, London SE1

Upcoming Conference on London Orthopaedic Meeting | 13th - 14th June 2024 | Lond …

We are pleased to announce the 1st Annual MarketsandMarkets London Orthopaedic Meeting, scheduled to take place on 13th-14th June 2024, in Radisson Park Plaza Waterloo,

Upcoming Conference on European Medical Device & Diagnostics Post-Market Surveil …

In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th

London Orthopaedic Conference | 3rd Annual MarketsandMarkets | 13th - 14th June …

We are pleased to announce the 3rd Annual MarketsandMarkets London Orthopaedic Meeting, scheduled to take place on 13th-14th June 2024, in London, UK. This conference

Next-Gen Immuno-Oncology Conference | Innovative Preclinical Models for Investig …

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and

Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …

MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual

High Potent Medicines Conference | Presentation by Global Speaker

Welcome to the MarketsandMarkets 9th High Potent Medicines Conference- the premier gathering for pioneers and experts in the realm of Highly Potent Active Pharmaceutical Ingredients

Unlocking Opportunities: European Regulatory Frameworks for Real-World Evidence …

In the realm of healthcare, the pursuit of evidence-based decision-making has been paramount. Real-world evidence (RWE) has emerged as a critical tool in this pursuit,

Real-World Evidence and Life Sciences Analytics Conference

Evidence Unveiled: Bridging Data Analytics and Evidence for Better Patient Outcomes We are thrilled to welcome you to the 7th Annual Real-World Evidence and Life Science

European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Con …

Empowering Excellence by Navigating the Future of Medical Devices & Diagnostics Introduction: In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance

Biomarker and Companion Diagnostics Conference - Boston, USA (June 20th-21st, 20 …

The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology

Next-Gen Immuno-Oncology Conference | 7th Annual MarketsandMarkets

Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and

Minimally Invasive Surgery Conference | 21st - 22nd March | London

Pushing the Boundaries of Minimally Invasive Technologies in Urology & Gynecology The field of surgery has experienced a remarkable evolution with the introduction of cutting-edge

Biomarker and Companion Diagnostics Conference | 2nd Annual MarketsandMarkets | …

From Discovery to Diagnosis: Bridging the Biomarker Gap MarketsandMarkets brings to you the Biomarker and Companion Diagnostics Conference scheduled to be held on 20th -

High Potent Medicines Conference - EU Edition | 9th Annual MarketsandMarkets

Looking at the current market scenario, many companies are outsourcing the manufacture of their highly potent compounds for various reasons, mainly marketing. The escalation in

Go To Page: